Table:
begin	end	state
1	19	cytoplasmic
20	39	transmembrane
40	50	non-cytoplasmic
51	76	transmembrane
77	87	cytoplasmic
88	111	transmembrane
112	116	non-cytoplasmic
117	118	transmembrane
119	122	non-cytoplasmic
123	142	transmembrane
143	153	cytoplasmic
154	175	transmembrane
176	186	non-cytoplasmic
187	206	transmembrane
207	237	cytoplasmic
238	256	transmembrane
257	275	non-cytoplasmic
276	295	transmembrane
296	304	cytoplasmic
305	326	transmembrane
327	337	non-cytoplasmic
338	358	transmembrane
359	367	cytoplasmic
368	390	transmembrane
391	401	non-cytoplasmic
402	419	transmembrane
420	432	cytoplasmic

Input:
>HSERO_RS07330
MTTTTTNAKHSKLSTVLRVTSGNFLEMFDFFLYGFYASYISKTFFPSDNEFVSLILTFGT
FGAGFLMRPLGAIILGSYIDRVGRRQGLIVTLAIMAIGTLLIAFVPGYATIGVAAPILVL
TGRLLQGFSAGVELGGVSVYLAEMATPGNKGFYVSWQSASQQAAIMASALIGYLVSQSLS
PVQISDWGWRIPFFIGCMIVPAIFIIRRSLQETDEFLARKRHPSFGEIMSSIAQNWKIVV
AGMMMVVMTTVSFYLITVYTPTFGKNVLKLSASDSLIVTFCVGLSNFCWLPIMGALSDRV
GRRPVLVAFTLLTLLTAYPVMSWLVSDISFKNLLITELWLSFLYASYNGAAVVALTEVMP
AHVRTVGFSLAYSLATAIFGGFTPLVSTWLIETSGDKAAPGYWMSFAAVCGLLATLVLYR
GKSAAATVSPTA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server